Arena Pharmaceuticals Other Liabilities

Arena Pharmaceuticals (ARNA) currently reports a other liabilities of $9M as of December 2021. That compares with $11M in the prior-year period — down 18.0% year over year. Use the charts on this page to explore Arena Pharmaceuticals's other liabilities history and peer comparisons.

Arena Pharmaceuticals's other liabilities decreased from $11M to $9M — a 18.0% year-over-year decrease (period ending December 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arena Pharmaceuticals reported $9M in other liabilities as of December 2021. That compares with $11M in the prior-year period — down 18.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Arena Pharmaceuticals, and consider following ARNA for alerts when major investors trade the stock.

Arena Pharmaceuticals is classified in the Healthcare sector. On other liabilities, it currently shows $9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ARNA with unrelated industries.